Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 381

1.

GLIS1, a novel hypoxia-inducible transcription factor, promotes breast cancer cell motility via activation of WNT5A.

Shimamoto K, Tanimoto K, Fukazawa T, Nakamura H, Kanai A, Bono H, Ono H, Eguchi H, Hirohashi N.

Carcinogenesis. 2020 Feb 12. pii: bgaa010. doi: 10.1093/carcin/bgaa010. [Epub ahead of print]

PMID:
32047936
2.

Targeting ROR1 in combination with pemetrexed in malignant mesothelioma cells.

Miyake N, Ochi N, Yamane H, Fukazawa T, Ikeda T, Yokota E, Takeyama M, Nakagawa N, Nakanishi H, Kohara H, Nagasaki Y, Kawahara T, Ichiyama N, Yamatsuji T, Naomoto Y, Takigawa N.

Lung Cancer. 2020 Jan;139:170-178. doi: 10.1016/j.lungcan.2019.10.024. Epub 2019 Nov 2.

PMID:
31809978
3.

Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages.

Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Suzuki H, Arakawa K, Hirai K, Fukazawa T, Ikota H, Shirabe K.

Pancreatology. 2019 Sep;19(6):897-902. doi: 10.1016/j.pan.2019.08.003. Epub 2019 Aug 7.

PMID:
31409525
4.

A case report of left lower lobe segmentectomy for pulmonary metastasis from retroperitoneal liposarcoma.

Yoshida K, Yoshida M, Haisa M, Yukawa T, Monobe Y, Naomoto Y, Fukazawa T, Yamatsuji T.

Int J Surg Case Rep. 2019;61:169-173. doi: 10.1016/j.ijscr.2019.07.059. Epub 2019 Jul 26.

5.

Simulated microgravity enhances CDDP-induced apoptosis signal via p53-independent mechanisms in cancer cells.

Fukazawa T, Tanimoto K, Shrestha L, Imura T, Takahashi S, Sueda T, Hirohashi N, Hiyama E, Yuge L.

PLoS One. 2019 Jul 19;14(7):e0219363. doi: 10.1371/journal.pone.0219363. eCollection 2019.

6.

Significance of Lymph Node Metastasis in Resectable Well-differentiated Pancreatic Neuroendocrine Tumor.

Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Suzuki H, Arakawa K, Hirai K, Fukazawa T, Ikota H, Shirabe K.

Pancreas. 2019 Aug;48(7):943-947. doi: 10.1097/MPA.0000000000001355.

PMID:
31268980
7.

Three-Component Repurposed Technology for Enhanced Expression: Highly Accumulable Transcriptional Activators via Branched Tag Arrays.

Kunii A, Hara Y, Takenaga M, Hattori N, Fukazawa T, Ushijima T, Yamamoto T, Sakuma T.

CRISPR J. 2018 Oct;1:337-347. doi: 10.1089/crispr.2018.0009.

8.

Effects of Chios mastic gum and exercise on physical characteristics, blood lipid markers, insulin resistance, and hepatic function in healthy Japanese men.

Fukazawa T, Smyrnioudis I, Konishi M, Takahashi M, Kim HK, Nishimaki M, Xiang M, Sakamoto S.

Food Sci Biotechnol. 2018 Jan 12;27(3):773-780. doi: 10.1007/s10068-018-0307-3. eCollection 2018 Jun.

9.

Erratum: Publisher Correction: Simulated microgravity attenuates myogenic differentiation via epigenetic regulations.

Furukawa T, Tanimoto K, Fukazawa T, Imura T, Kawahara Y, Yuge L.

NPJ Microgravity. 2018 Jul 18;4:15. doi: 10.1038/s41526-018-0047-y. eCollection 2018.

10.

Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma.

Yoshida M, Yokota E, Sakuma T, Yamatsuji T, Takigawa N, Ushijima T, Yamamoto T, Fukazawa T, Naomoto Y.

Oncotarget. 2018 Jun 26;9(49):29220-29232. doi: 10.18632/oncotarget.25678. eCollection 2018 Jun 26.

11.

Simulated microgravity attenuates myogenic differentiation via epigenetic regulations.

Furukawa T, Tanimoto K, Fukazawa T, Imura T, Kawahara Y, Yuge L.

NPJ Microgravity. 2018 May 23;4:11. doi: 10.1038/s41526-018-0045-0. eCollection 2018. Erratum in: NPJ Microgravity. 2018 Jul 18;4:15.

12.

Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis.

Sato K, Niino M, Kawashima A, Yamada M, Miyazaki Y, Fukazawa T.

Intern Med. 2018 Sep 15;57(18):2647-2655. doi: 10.2169/internalmedicine.0793-18. Epub 2018 Apr 27.

13.

An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo.

Tomoshige K, Guo M, Tsuchiya T, Fukazawa T, Fink-Baldauf IM, Stuart WD, Naomoto Y, Nagayasu T, Maeda Y.

Oncogene. 2018 Jul;37(28):3894-3908. doi: 10.1038/s41388-018-0240-1. Epub 2018 Apr 17.

PMID:
29662194
14.

Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.

Koda T, Namba A, Nakatsuji Y, Niino M, Miyazaki Y, Sugimoto T, Kinoshita M, Takata K, Yamashita K, Shimizu M, Fukazawa T, Kumanogoh A, Mochizuki H, Okuno T.

PLoS One. 2018 Mar 8;13(3):e0193986. doi: 10.1371/journal.pone.0193986. eCollection 2018.

15.

Health-related quality of life on the clinical course of patients with chronic hepatitis C receiving daclatasvir/asunaprevir therapy: A prospective observational study comparing younger (<70) and elderly (≥70) patients.

Ohashi K, Ishikawa T, Suzuki M, Abe H, Koyama F, Nakano T, Ueki A, Noguchi H, Hasegawa E, Hirosawa S, Kobayashi M, Hirosawa H, Sato K, Fukazawa T, Maruyama Y, Yoshida T.

Exp Ther Med. 2018 Jan;15(1):970-976. doi: 10.3892/etm.2017.5488. Epub 2017 Nov 10.

16.

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan.

Niino M, Fukazawa T, Kira JI, Okuno T, Mori M, Sanjo N, Ohashi T, Fukaura H, Fujimori J, Shimizu Y, Mifune N, Miyazaki Y, Takahashi E, Kikuchi S, Langdon D, Hb Benedict R, Matsui M.

Mult Scler J Exp Transl Clin. 2017 Dec 26;3(4):2055217317748972. doi: 10.1177/2055217317748972. eCollection 2017 Oct-Dec.

17.

Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma.

Yokota E, Yamatsuji T, Takaoka M, Haisa M, Takigawa N, Miyake N, Ikeda T, Mori T, Ohno S, Sera T, Fukazawa T, Naomoto Y.

Oncotarget. 2017 Oct 5;8(61):103063-103076. doi: 10.18632/oncotarget.21523. eCollection 2017 Nov 28.

18.

Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis.

Miyazaki Y, Niino M, Takahashi E, Suzuki M, Mizuno M, Hisahara S, Fukazawa T, Amino I, Nakano F, Nakamura M, Akimoto S, Minami N, Fujiki N, Doi S, Shimohama S, Terayama Y, Kikuchi S.

Clin Immunol. 2018 Feb;187:95-101. doi: 10.1016/j.clim.2017.10.009. Epub 2017 Oct 25.

PMID:
29079163
19.

interleukin-11 induces and maintains progenitors of different cell lineages during Xenopus tadpole tail regeneration.

Tsujioka H, Kunieda T, Katou Y, Shirahige K, Fukazawa T, Kubo T.

Nat Commun. 2017 Sep 8;8(1):495. doi: 10.1038/s41467-017-00594-5.

20.

Once-daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing-remitting multiple sclerosis.

Yamamura T, Ashtamker N, Ladkani D, Fukazawa T, Houzen H, Tanaka M, Miura T, Knappertz V.

Clin Exp Neuroimmunol. 2017 May;8(2):129-137. doi: 10.1111/cen3.12383. Epub 2017 Mar 23.

21.

Alternative Internal Standard Calibration of an Indirect Enzymatic Analytical Method for 2-MCPD Fatty Acid Esters.

Koyama K, Miyazaki K, Abe K, Egawa Y, Fukazawa T, Kitta T, Miyashita T, Nezu T, Nohara H, Sano T, Takahashi Y, Taniguchi H, Yada H, Yamazaki K, Watanabe Y.

J Oleo Sci. 2017 Jun 1;66(6):585-590. doi: 10.5650/jos.ess16229. Epub 2017 May 17.

22.

Gene signature driving invasive mucinous adenocarcinoma of the lung.

Guo M, Tomoshige K, Meister M, Muley T, Fukazawa T, Tsuchiya T, Karns R, Warth A, Fink-Baldauf IM, Nagayasu T, Naomoto Y, Xu Y, Mall MA, Maeda Y.

EMBO Mol Med. 2017 Apr;9(4):462-481. doi: 10.15252/emmm.201606711.

23.

Enantioselective Access to Bicyclo[3.2.1]octadienone Skeleton: Total Syntheses of (+)-Engelharquinone and Its Epoxide.

Fukazawa T, Ando Y, Ohmori K, Hayashi T, Suzuki K.

Org Lett. 2017 Mar 17;19(6):1470-1473. doi: 10.1021/acs.orglett.7b00464. Epub 2017 Mar 1.

PMID:
28248526
24.

Evaluation of the health-related quality of life using the 36-item short form health survey in patients with chronic hepatitis C receiving pegylated interferon/ribavirin/telaprevir triple treatment.

Suzuki M, Ishikawa T, Sakuma A, Abe S, Abe H, Koyama F, Nakano T, Ueki A, Noguchi H, Hasegawa E, Yamagata S, Kobayashi M, Ohashi K, Hirosawa H, Fukazawa T, Maruyama Y, Yoshida T.

Exp Ther Med. 2016 Nov;12(5):3353-3358. Epub 2016 Oct 5.

25.

Acute phase response in amputated tail stumps and neural tissue-preferential expression in tail bud embryos of the Xenopus neuronal pentraxin I gene.

Hatta-Kobayashi Y, Toyama-Shirai M, Yamanaka T, Takamori M, Wakabayashi Y, Naora Y, Kunieda T, Fukazawa T, Kubo T.

Dev Growth Differ. 2016 Dec;58(9):688-701. doi: 10.1111/dgd.12326. Epub 2016 Nov 2.

PMID:
27804121
26.

A Case of Birt-Hogg-Dubé (BHD) Syndrome Harboring a Novel Folliculin (FLCN) Gene Mutation.

Yukawa T, Fukazawa T, Yoshida M, Morita I, Kato K, Monobe Y, Furuya M, Naomoto Y.

Am J Case Rep. 2016 Oct 26;17:788-792.

27.

Fingolimod suppresses bone resorption in female patients with multiple sclerosis.

Miyazaki Y, Niino M, Kanazawa I, Suzuki M, Mizuno M, Hisahara S, Fukazawa T, Takahashi E, Amino I, Ochi R, Nakamura M, Akimoto S, Minami N, Fujiki N, Doi S, Shimohama S, Terayama Y, Kikuchi S.

J Neuroimmunol. 2016 Sep 15;298:24-31. doi: 10.1016/j.jneuroim.2016.06.007. Epub 2016 Jun 24.

PMID:
27609272
28.

Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.

Nakamura Y, Matsushita T, Sato S, Niino M, Fukazawa T, Yoshimura S, Hisahara S, Isobe N, Shimohama S, Watanabe M, Yoshida K, Houzen H, Miyazaki Y, Yamasaki R, Kikuchi S, Kira J; Japan Multiple Sclerosis Genetics Consortium.

J Neuroinflammation. 2016 Sep 6;13(1):239. doi: 10.1186/s12974-016-0695-3.

29.

The dynamics of mucosal-associated invariant T cells in multiple sclerosis.

Sugimoto C, Hirotani M, Yoshikiyo K, Koshimizu U, Wakao R, Horinouchi T, Mazaki Y, Higashi T, Fukazawa T, Fujita H, Sasaki H, Wakao H.

Springerplus. 2016 Aug 5;5(1):1259. doi: 10.1186/s40064-016-2923-9. eCollection 2016.

30.

Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO.

Higuchi O, Nakane S, Sakai W, Maeda Y, Niino M, Takahashi T, Fukazawa T, Kikuchi S, Fujihara K, Matsuo H.

Neurol Neuroimmunol Neuroinflamm. 2016 Jul 22;3(5):e263. doi: 10.1212/NXI.0000000000000263. eCollection 2016 Oct.

31.

Aqueous-Medium Carbon-Carbon Bond-Forming Radical Reactions Catalyzed by Excited Rhodamine B as a Metal-Free Organic Dye under Visible Light Irradiation.

Yoshioka E, Kohtani S, Jichu T, Fukazawa T, Nagai T, Kawashima A, Takemoto Y, Miyabe H.

J Org Chem. 2016 Aug 19;81(16):7217-29. doi: 10.1021/acs.joc.6b01102. Epub 2016 Jun 28.

PMID:
27314306
32.

Novel Midkine Inhibitor iMDK Inhibits Tumor Growth and Angiogenesis in Oral Squamous Cell Carcinoma.

Masui M, Okui T, Shimo T, Takabatake K, Fukazawa T, Matsumoto K, Kurio N, Ibaragi S, Naomoto Y, Nagatsuka H, Sasaki A.

Anticancer Res. 2016 Jun;36(6):2775-81.

33.

Phyhd1, an XPhyH-like homologue, is induced in mouse T cells upon T cell stimulation.

Furusawa Y, Kubo T, Fukazawa T.

Biochem Biophys Res Commun. 2016 Apr 8;472(3):551-6. doi: 10.1016/j.bbrc.2016.03.039. Epub 2016 Mar 10.

PMID:
26970303
34.

SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.

Fukazawa T, Guo M, Ishida N, Yamatsuji T, Takaoka M, Yokota E, Haisa M, Miyake N, Ikeda T, Okui T, Takigawa N, Maeda Y, Naomoto Y.

Sci Rep. 2016 Feb 5;6:20113. doi: 10.1038/srep20113.

35.

Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.

Yamasaki R, Matsushita T, Fukazawa T, Yokoyama K, Fujihara K, Ogino M, Yokota T, Miyamoto K, Niino M, Nomura K, Tomioka R, Tanaka M, Kawachi I, Ohashi T, Kaida K, Matsui M, Nakatsuji Y, Ochi H, Fukaura H, Kanda T, Nagaishi A, Togo K, Mizusawa H, Murai H, Kira J.

Mult Scler. 2016 Sep;22(10):1337-48. doi: 10.1177/1352458515617248. Epub 2015 Nov 12.

PMID:
26564994
36.

Enzymatic Analysis of Positional Fatty Acid Distributions in Triacylglycerols by 1(3)-Selective Transesterification with Candida antarctica Lipase B: a Collaborative Study.

Watanabe Y, Sato S, Asada M, Arishima T, Iida Y, Imagi J, Saito K, Sano T, Sasaki A, Sasaki R, Sato C, Shibuya T, Tsukahara Y, Nagai T, Fukazawa T, Hori R, Homma R, Miyazaki Y, Yamashita A, Yoshinaga K, Watanabe S.

J Oleo Sci. 2015;64(11):1193-205. doi: 10.5650/jos.ess15182.

37.

Copy number variations in multiple sclerosis and neuromyelitis optica.

Sato S, Yamamoto K, Matsushita T, Isobe N, Kawano Y, Iinuma K, Niino M, Fukazawa T, Nakamura Y, Watanabe M, Yonekawa T, Masaki K, Yoshimura S, Murai H, Yamasaki R, Kira J; Japan Multiple Sclerosis Genetics Consortium.

Ann Neurol. 2015 Nov;78(5):762-74. doi: 10.1002/ana.24511. Epub 2015 Sep 18.

PMID:
26296936
38.

Toward Naphthocyclinones: Doubly Connected Octaketide Dimers with a Bicyclo[3.2.1]octadienone Core by Thiolate-Mediated Cyclization.

Ando Y, Hori S, Fukazawa T, Ohmori K, Suzuki K.

Angew Chem Int Ed Engl. 2015 Aug 10;54(33):9650-3. doi: 10.1002/anie.201503442. Epub 2015 Jun 26.

PMID:
26118656
39.

[I. The past and present of Doshomachi].

Fukazawa T.

Nihon Ishigaku Zasshi. 2015 Mar;61(1):14-6. Japanese. No abstract available.

PMID:
26062216
40.

A novel PI3K inhibitor iMDK suppresses non-small cell lung Cancer cooperatively with A MEK inhibitor.

Ishida N, Fukazawa T, Maeda Y, Yamatsuji T, Kato K, Matsumoto K, Shimo T, Takigawa N, Whitsett JA, Naomoto Y.

Exp Cell Res. 2015 Jul 15;335(2):197-206. doi: 10.1016/j.yexcr.2015.03.019. Epub 2015 Apr 1.

41.

Optimized effective potential method and application to static RPA correlation.

Fukazawa T, Akai H.

J Phys Condens Matter. 2015 Mar 25;27(11):115502. doi: 10.1088/0953-8984/27/11/115502. Epub 2015 Mar 4.

PMID:
25739010
42.

Egress of mature murine regulatory T cells from the thymus requires RelA.

Fukazawa T, Hiraiwa N, Umemura T, Mise-Omata S, Obata Y, Doi T.

J Immunol. 2015 Apr 1;194(7):3020-8. doi: 10.4049/jimmunol.1302756. Epub 2015 Feb 27.

43.

Decreased serum vitamin D levels in Japanese patients with multiple sclerosis.

Niino M, Sato S, Fukazawa T, Masaki K, Miyazaki Y, Matsuse D, Yamasaki R, Takahashi E, Kikuchi S, Kira J.

J Neuroimmunol. 2015 Feb 15;279:40-5. doi: 10.1016/j.jneuroim.2015.01.007. Epub 2015 Jan 23.

PMID:
25669999
44.

Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis.

Niino M, Sato S, Fukazawa T, Yoshimura S, Hisahara S, Matsushita T, Isobe N, Yoshida K, Houzen H, Miyazaki Y, Shimohama S, Kikuchi S, Kira J.

Mult Scler. 2015 Aug;21(9):1112-20. doi: 10.1177/1352458514560924. Epub 2015 Jan 12.

PMID:
25583844
45.

[Home hospice care, working support and rehabilitation for MS/NMO].

Fukazawa T, Okazaki F, Sawai M, Nishiyama K.

Nihon Rinsho. 2014 Nov;72(11):2045-50. Japanese.

PMID:
25518391
46.

[Vitamin D and latitude as environmental factors in multiple sclerosis].

Niino M, Miyazaki Y, Fukazawa T, Kikuchi S.

Nihon Rinsho. 2014 Nov;72(11):1924-9. Japanese.

PMID:
25518372
47.

Inhibitory activities of selected Kampo formulations on human aldose reductase.

Onoda T, Ishikawa C, Fukazawa T, Li W, Obayashi M, Koike K.

BMC Complement Altern Med. 2014 Nov 6;14:435. doi: 10.1186/1472-6882-14-435.

48.

A case of autoimmune pulmonary alveolar proteinosis appearing as a localized ground-glass opacity.

Kojima K, Kato K, Fukazawa T, Morita I, Takigawa N, Monobe Y, Shibamoto K, Soda Y, Mimura H.

Jpn J Radiol. 2014 Nov;32(11):657-60. doi: 10.1007/s11604-014-0348-3. Epub 2014 Aug 23.

PMID:
25149419
49.

Control of algal production in a high rate algal pond: investigation through batch and continuous experiments.

Derabe Maobe H, Onodera M, Takahashi M, Satoh H, Fukazawa T.

Water Sci Technol. 2014;69(12):2519-25. doi: 10.2166/wst.2014.174.

PMID:
24960016
50.

NF-κB RELA-deficient bone marrow macrophages fail to support bone formation and to maintain the hematopoietic niche after lethal irradiation and stem cell transplantation.

Mise-Omata S, Alles N, Fukazawa T, Aoki K, Ohya K, Jimi E, Obata Y, Doi T.

Int Immunol. 2014 Nov;26(11):607-18. doi: 10.1093/intimm/dxu062. Epub 2014 Jun 7.

PMID:
24908679

Supplemental Content

Loading ...
Support Center